AzTrials
AzTrials

ACTNCT07538011

An ACT-Based Family Psychosocial Intervention for Women With Perinatal Loss and Their Spouses: A Pilot Randomised Controlled Trial

A study testing Acceptance and Commitment Therapy in people with ACT and Perinatal Loss, run by Second Xiangya Hospital of Central South University at 3 sites in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

This pilot randomised controlled trial evaluates the feasibility, acceptability, and preliminary effects of an Acceptance and Commitment Therapy (ACT)-based family psychosocial intervention for women requiring medically indicated induction of labour because of fetal or maternal health problems, together with their… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
ACT, Perinatal Loss, Mental Health
What is being tested?
Acceptance and Commitment Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
88 participants
Where
3 sitesChina
Study dates
10 Apr 2026to 30 Aug 2026
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Women aged 18 years or older.
  • Diagnosed as requiring induction of labour because of fetal or maternal health problems.
  • A spouse willing to participate in the intervention as the primary caregiver.
  • Ability to use a smartphone, tablet, or computer to complete the online psychological intervention and questionnaires.
  • Provision of written informed consent.

Who cannot join

  • Life-threatening severe complications, including heart failure, eclampsia, severe pre-eclampsia, or major haemorrhage.
  • A diagnosed psychological or psychiatric illness, or evident self-harm or suicidal tendencies or behaviour.
  • Current participation in a related support intervention or participation in such an intervention within the preceding 30 days.

Trial locations and contacts

3 sites in 1 country.

China3 sites
  • The Second Xiangya Hospital, Central South University

    Changsha, Hunan, 410000

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, 410000

  • Xiangya Hospital of Central South University

    Changsha, Hunan, 410000

Other trials in China

About this study

Official title: Feasibility, Acceptability, and Preliminary Effects of an Acceptance and Commitment Therapy-Based Family Psychosocial Intervention for Women With Perinatal Loss and Their Spouses: A Pilot Randomised Controlled Trial

This pilot randomised controlled trial evaluates the feasibility, acceptability, and preliminary effects of an Acceptance and Commitment Therapy (ACT)-based family psychosocial intervention for women requiring medically indicated induction of labour because of fetal or maternal health problems, together with their spouses as primary caregivers. The study is conducted at three tertiary hospitals in Changsha, Hunan, China. The target sample is 44 woman-spouse dyads, allocated 1:1 to usual care plus the intervention or usual care alone.

The approximately 3-month intervention comprises eight sessions: four face-to-face hospital sessions lasting 30-60 minutes and four online dyadic sessions via Tencent Meeting lasting 20-45 minutes. The post-discharge online sessions (Sessions 5 to 8) are conducted within 3 days, in the second week, in the first month, and in the third month (booster session) following the patient's discharge. Outcomes are assessed at baseline before randomisation (T0) and within 1 week after intervention completion (T1), with corresponding assessment timing in the control group. Perinatal grief is the primary effectiveness outcome. Secondary outcomes include depression, anxiety, post-traumatic stress symptoms, psychological flexibility, health information literacy, mindful self-care, and perceived social support. Feasibility is assessed through recruitment, adherence, implementation, attrition, and reasons for withdrawal. Intervention-group dyads jointly complete an 17-item satisfaction questionnaire at T1 and are invited to qualitative interviews within 1 week after intervention completion.

Read the detailed description

Background The intervention is informed by the transactional model of stress and cognitive appraisal and the findings of the research programme. It combines perinatal loss health education, ACT-based psychological support, rehabilitation activities including mindful yoga, and family social support. ACT addresses acceptance, cognitive defusion, contact with the present moment, self-as-context, values clarification, and committed action.

Before pilot testing, intervention content was reviewed through two to three rounds of Delphi consultation with eight experts: two psychology experts, three obstetricians, and three obstetric nurses. Each expert had more than 10 years of experience and a senior professional title. Relevance, clarity, readability, and appropriateness were rated on a 4-point scale. Two women with previous perinatal loss and education no higher than high school also reviewed comprehensibility and relevance to their needs. All final expert item ratings were at least 3, and minor revisions informed the pilot intervention.

Intervention This study tests a 3-month ACT-based psychosocial intervention delivered across eight sessions (45-60 minutes each). The intervention integrates four thematic components: (1) perinatal loss health education; (2) ACT-based grief and emotion management (acceptance, defusion, present-moment awareness, values, committed action); (3) postpartum rehabilitation mindfulness yoga; and (4) social support from significant others.

Delivery format is mixed to accommodate the inpatient-to-outpatient transition:

Sessions 1-4: In-person, hospital setting, one-on-two format (woman plus spouse/significant other), covering the inpatient period (admission, induction procedure, postoperative recovery).

Sessions 5-7: Remote via Tencent Meeting (videoconferencing), one-on-two format, covering the post-discharge physical and emotional recovery period.

Booster session (session 8): 30-minute remote session three month after discharge.

Participants receive a workbook containing session summaries and homework assignments. QR codes in the workbook provide access to online instructional videos for home-based mindfulness meditation or mindfulness yoga practice.

Study Design This is a two-arm, assessor-masked, parallel-group pilot randomised controlled trial conducted at three tertiary hospitals in Changsha, Hunan, China. Woman-spouse dyads are allocated in a 1:1 ratio to usual care plus the family psychosocial intervention or usual care alone. Block randomisation uses a block size of four. An independent research assistant, a registered nurse with a bachelor's degree in nursing, generates the allocation sequence using an online randomisation programme and is not involved in recruitment, intervention delivery, or outcome analysis.

Allocation is concealed using sequentially numbered, sealed, opaque envelopes prepared by the research assistant and delivered to participants by the project manager. Outcome assessment uses online questionnaires, with participant identifiers and allocation coded before analysis to support assessor masking. Process evaluation and a descriptive qualitative component inform refinement of the intervention.

Participants, Sample Size, and Recruitment The target sample is 44 woman-spouse dyads, with 22 dyads per arm. The sample-size rationale uses a pilot-study minimum of 30 and an anticipated attrition rate of 32% from the preceding systematic review and meta-analysis. This is a pilot sample intended to evaluate feasibility, acceptability, and preliminary effects.

Convenience sampling is used. After ethics approval at each hospital, midwives distribute recruitment information through hospital online platforms and posters. Interested women undergo eligibility screening through the responsible midwife and meet a research assistant to discuss the study purpose, procedures, benefits, risks, and the right to withdraw before providing written informed consent.

Outcome Measures

Quantitative measures:

Feasibility is assessed through eligibility and consent rates, reasons for declining participation, adherence, intervention implementation, attrition, and reasons for withdrawal. Intervention completion is defined as attending at least six of the eight sessions (at least 75%).

Acceptability is assessed in the intervention group using an 17-item study-specific satisfaction questionnaire adapted from the 15-item Chinese Standardized Client Satisfaction Scale and qualitative interviews at T1. Each woman and her spouse complete the satisfaction questionnaire jointly.

The primary preliminary-effectiveness outcome is perinatal grief, measured using the Perinatal Grief Scale (PGS-15). Secondary outcomes for women are depressive symptoms (PHQ-9), anxiety symptoms (GAD-7), post-traumatic stress symptoms (IES-R), psychological flexibility (Psy-Flex-C), health information literacy (HILS), mindful self-care (B-MSCS), and Multidimensional Scale of perceived social support (MSPSS).

Qualitative component:

All women and spouses in the intervention group (target: 22 dyads) are invited to semi-structured interviews within 1 week after intervention completion (T1). Trained research assistants conduct the interviews through Tencent Meeting to explore experiences, perceived facilitators, barriers, and benefits. Interviews are digitally audio-recorded with consent using an iFlytek SR701 recorder.

The first author transcribes the recordings verbatim and a research assistant checks the transcripts. Content analysis is conducted with NVivo following Bengtsson's four stages: decontextualisation, recontextualisation, categorisation, and compilation.

Assessment Schedule Baseline data (T0), including demographics and primary and secondary outcomes, are collected online with research-assistant support before randomisation. Post-intervention assessment (T1) occurs within 1 week after completion of the approximately 3-month intervention, including the final booster session. The intervention group completes primary and secondary outcome questionnaires and the satisfaction questionnaire and is invited to qualitative interviews during this week. The control group completes only the primary and secondary outcome questionnaires over the corresponding time interval.

Data Management and Quality Control Data are collected through Questionnaire Star (WJX). Records use study identification codes and are password-protected. Paper records are stored in locked cabinets; electronic records are stored on password-protected USB drives with password-protected cloud backup accessible only to the research team. Records are retained for 6 years and then destroyed. Audio recording requires participant consent.

Participation is voluntary, written informed consent is obtained, and participants may pause or withdraw without penalty. If self-harm or suicidal tendencies are reported or identified, the research assistant informs the principal investigator, who facilitates access to medical support and, with participant consent, informs the emergency contact. Intervention contacts include physical and psychological risk review and referral as required.

Data Analysis Quantitative data are analysed using R with a significance level of 0.05. Descriptive statistics summarise demographic and clinical characteristics, implementation measures, and outcome scores. Distributional characteristics are examined using skewness, kurtosis, normality tests, histograms, and Q-Q plots. Baseline continuous variables are compared using independent-samples t tests or Mann-Whitney U tests as appropriate; categorical variables are compared using continuity-corrected chi-square tests or Fisher's exact tests.

For non-normally distributed outcome data, within-group changes from T0 to T1 are examined using Wilcoxon signed-rank tests and between-group comparisons use Mann-Whitney U tests. Between-group effect sizes at T1 are estimated using Hedges' g.

Qualitative data are analysed with NVivo using Bengtsson's content-analysis stages of decontextualisation, recontextualisation, categorisation, and compilation. Recordings are transcribed verbatim by the first author and checked by a research assistant.

Study Objectives The pilot evaluates whether the family psychosocial intervention can be delivered as planned, its acceptability to women and their spouses, and preliminary differences between the intervention and usual-care groups in changes in perinatal grief and secondary outcomes from T0 to T1. Feasibility and acceptability findings will inform intervention refinement. Intervention completion is defined as attendance at six or more of the eight sessions.

Being tested
Acceptance and Commitment Therapy
Keywords
ACT, Mental Health, perinatal loss, Pilot RCT
Medical subject headings
Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acceptance and Commitment TherapyBehavioural

    Session Outline Session 1: Diagnostic clarification and emotional stabilisation on admission; 45-60 minutes.

    Session 2: Preparation for induction and trauma stabilisation after the treatment plan is agreed and before induction; 45-60 minutes.

    Session 3: Acknowledgement of grief and voluntary remembrance within 24-48 hours after induction, adjusted to physical condition; 30-60 minutes.

    Session 4: Rehabilitation, self-care, and a family support plan on the day before discharge or the discharge day; within the 30-60-minute inpatient-session range.

    Session 5: Post-discharge physical and psychological safety review and continuity of support within 3 days after discharge; 20-30 minutes.

    Session 6: Values clarification and anxiety management at 2 weeks after discharge; 30-45 minutes.

    Session 7: Consolidation of self-care and connection to clinical, community, and peer resources at 1 month after discharge; 20-30 minutes.

    Session 8: Booster focusing on anxiety, future pregnancy concerns.

Study groups in NCT07538011
Study groupRoleWhat they receive
intervention groupExperimentalWomen and their spouses receive routine ward care plus an approximately 3-month, eight-session ACT-based family psychosocial intervention. Four inpatient face-to-face sessions (30-60 minutes each) are followed by four online dyadic sessions via Tencent Meeting (20-45 minutes each), within 3 days, at 2 weeks, at 1 month, and at 3 months after discharge. The final session is a booster included in the eight-session total. Each session involves one interventionist with the woman and her spouse. The programme combines health education, ACT-based grief and emotion management, rehabilitation, and family social support, supported by a workbook and home-practice videos.
Receives: Behavioral: Acceptance and Commitment Therapy
Control groupNo interventionWomen and their spouses receive routine care provided by their hospital ward, including admission assessment, basic nursing care, medication instructions, precautions following induction of labour, discharge guidance, and information about follow-up appointments. No additional study-specific family psychosocial intervention is provided.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perinatal Grief

    Measured by the 15-item Perinatal Grief Scale Short Form (15-PGS-SF; Li et al., 2025). Higher scores indicate more severe grief symptoms.

    Measured: Baseline (T0, before randomisation) and immediately post-intervention (T1, within 1 week after completion of intervention)

Secondary outcomes (7)
  1. Depressive Symptoms

    Measured by the Patient Health Questionnaire-9 (PHQ-9; Wang et al., 2014). Higher scores indicate more severe depressive symptoms.

    Measured: Baseline (T0, before randomisation) and immediately post-intervention (T1, within 1 week after completion of intervention)

  2. Anxiety Symptoms

    Measured by the Generalized Anxiety Disorder-7 (GAD-7; Zeng et al., 2013). Higher scores indicate more severe anxiety symptoms.

    Measured: Baseline (T0, before randomisation) and immediately post-intervention (T1, within 1 week after completion of intervention)

  3. Post-Traumatic Stress Symptoms

    Measured by the Impact of Event Scale-Revised (IES-R; Wu \& Chan, 2004). Higher scores indicate more severe post-traumatic stress symptoms.

    Measured: Baseline (T0, before randomisation) and immediately post-intervention (T1, within 1 week after completion of intervention)

  4. Psychological Flexibility

    Measured by the Psy-Flex-C (Li et al., 2024a). Higher scores indicate greater psychological flexibility.

    Measured: Baseline (T0, before randomisation) and immediately post-intervention (T1, within 1 week after completion of intervention)

  5. Perceived Social Support

    Measured by the Multidimensional Scale of Perceived Social Support Scale (MSPSS; Yang, 2024). Higher scores indicate greater perceived social support.

    Measured: Baseline (T0, before randomisation) and immediately post-intervention (T1, within 1 week after completion of intervention)

  6. Health Information Literacy

    Measured by the Health Information Literacy Self-rating Scale.

    Measured: Baseline (T0, before randomisation) and immediately post-intervention (T1, within 1 week after completion of intervention).

  7. Self-Care

    Measured by the Mindful Self-Care Scale - Brief (B-MSCS).

    Measured: Baseline (T0, before randomisation) and immediately post-intervention (T1, within 1 week after completion of intervention).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2026
  2. Study start10 Apr 2026
  3. Primary completion30 Aug 2026
  4. Study completion30 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
88 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07538011
Sponsor's protocol ID
LYEC2025
Status last verified
Sep 2026
First submitted
10 Apr 2026
Last updated
2 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Considering ethical reasons and participant privacy, we will not make individual participant data publicly available.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in